Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 405416

Adjuvant endocrine therapy for perimenopausal women with early breast cancer

Ortmann, O.; Čufer, Tanja; Dixon, J.M.; Maas, N.; Marchetti, P.; Pagani, O.; Pronzato, P.; Semiglazov, V.; Spano, J.P.; Vrdoljak, Eduard; Wildiers, H.
Adjuvant endocrine therapy for perimenopausal women with early breast cancer // Breast, 18 (2009), 1; 2-7 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 405416 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Adjuvant endocrine therapy for perimenopausal women with early breast cancer

Autori
Ortmann, O. ; Čufer, Tanja ; Dixon, J.M. ; Maas, N. ; Marchetti, P. ; Pagani, O. ; Pronzato, P. ; Semiglazov, V. ; Spano, J.P. ; Vrdoljak, Eduard ; Wildiers, H.

Izvornik
Breast (0167-6806) 18 (2009), 1; 2-7

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
breast cancer; perimenopausal; endocrine therapy

Sažetak
Adjuvant treatment with aromatase inhibitors (AIs) improves outcomes in postmenopausal women with hormone-sensitive early breast cancer compared with tamoxifen. However, AIs should not be used in premenopausal women because they can paradoxically increase estrogen secretion and may therefore stimulate tumor progression. In perimenopausal women undergoing treatment for breast cancer, it can be difficult to determine true menopausal status because adjuvant chemotherapy, tamoxifen, and gonadotropin-releasing hormone analogues can induce transient (or permanent) ovarian suppression. How can one determine whether these women are truly postmenopausal and therefore candidates for AI therapy? A panel of experts in the field of endocrine therapy in breast cancer met in Dubrovnik, Croatia, on October 23, 2006, to discuss this clinical dilemma. This report summarizes the conclusions and recommendations that arose from this discussion.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Projekti:
216-0000000-0484 - Dvostruki model ovarijalne kancerogeneze - molekularna i morfološka studija (Tomić, Snježana, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url Eduard Vrdoljak (autor)

Citiraj ovu publikaciju:

Ortmann, O.; Čufer, Tanja; Dixon, J.M.; Maas, N.; Marchetti, P.; Pagani, O.; Pronzato, P.; Semiglazov, V.; Spano, J.P.; Vrdoljak, Eduard; Wildiers, H.
Adjuvant endocrine therapy for perimenopausal women with early breast cancer // Breast, 18 (2009), 1; 2-7 (međunarodna recenzija, članak, znanstveni)
Ortmann, O., Čufer, T., Dixon, J., Maas, N., Marchetti, P., Pagani, O., Pronzato, P., Semiglazov, V., Spano, J., Vrdoljak, E. & Wildiers, H. (2009) Adjuvant endocrine therapy for perimenopausal women with early breast cancer. Breast, 18 (1), 2-7.
@article{article, author = {Ortmann, O. and \v{C}ufer, Tanja and Dixon, J.M. and Maas, N. and Marchetti, P. and Pagani, O. and Pronzato, P. and Semiglazov, V. and Spano, J.P. and Vrdoljak, Eduard and Wildiers, H.}, year = {2009}, pages = {2-7}, keywords = {breast cancer, perimenopausal, endocrine therapy}, journal = {Breast}, volume = {18}, number = {1}, issn = {0167-6806}, title = {Adjuvant endocrine therapy for perimenopausal women with early breast cancer}, keyword = {breast cancer, perimenopausal, endocrine therapy} }
@article{article, author = {Ortmann, O. and \v{C}ufer, Tanja and Dixon, J.M. and Maas, N. and Marchetti, P. and Pagani, O. and Pronzato, P. and Semiglazov, V. and Spano, J.P. and Vrdoljak, Eduard and Wildiers, H.}, year = {2009}, pages = {2-7}, keywords = {breast cancer, perimenopausal, endocrine therapy}, journal = {Breast}, volume = {18}, number = {1}, issn = {0167-6806}, title = {Adjuvant endocrine therapy for perimenopausal women with early breast cancer}, keyword = {breast cancer, perimenopausal, endocrine therapy} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Podijeli:





Contrast
Increase Font
Decrease Font
Dyslexic Font
CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.